Figure 5. Overall and event free survival of AML and MDS patients with blasts in the peripheral blood at time of HCT. AML/MDS patients: OS (A) and EFS (B) of the subgroup of patients with blasts in the peripheral blood at the time of HCT (n = 33).
Figure 5

Overall and event free survival of AML and MDS patients with blasts in the peripheral blood at time of HCT. AML/MDS patients: OS (A) and EFS (B) of the subgroup of patients with blasts in the peripheral blood at the time of HCT (n = 33).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal